Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Berberine and neurodegeneration: A review of literature.
Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity.
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis.
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis.
Polyarteritis nodosa with central nervous system involvement mimicking relapsing-remitting multiple sclerosis.
Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes.
Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis.
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
A case of hereditary diffuse leukoencephalopathy with axonal spheroids caused by a de novo mutation in CSF1R masquerading as primary progressive multiple sclerosis.
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis.
Treating prolactinoma can prevent autoimmune diseases.
Plant sterols: Friend or foe in CNS disorders?
Genome-Wide DNA Methylation Profiles Indicate CD8+ T Cell Hypermethylation in Multiple Sclerosis.
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study.
Development and validation of the Dutch version of the London Handicap Scale.
MAL Overexpression Leads to Disturbed Expression of Genes That Influence Cytoskeletal Organization and Differentiation of Schwann Cells.
Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS.
Endogenous and synthetic MMP inhibitors in CNS physiopathology.
Comment on: Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
The Effect of Biofeedback as a Psychological Intervention in Multiple Sclerosis: A Randomized Controlled Study.
Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter.
Oligoclonal bands in multiple sclerosis patients: worse prognosis?
Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis.
Pelvic floor disorders and multiple sclerosis: are patients satisfied with their care?
Pages
« first
‹ previous
…
534
535
536
537
538
539
540
541
542
…
next ›
last »